MetaGene and Applied Spectral Imaging (ASI) are proud to offer Australia's first QDP-IHC Section and support the Menzies Health Institute Queensland in the creation of the country’s first Quantitative Digital Pathology – Immunohistochemistry Section (QDP-IHC). This department will utilise the GenASIs Digital Pathology platform, approved...
[video width="640" height="360" mp4="https://metagene.com.au/wp-content/uploads/2017/10/MetaGene_7NewsBrisbane_26102017.mp4"][/video] Diagnostic digital pathology system improving the landscape of cancer diagnosis In an Australian first, the Federal Government has granted TGA approval for a diagnostic digital pathology system set to radically improve the outlook for cancer patients through rapid and accurate diagnosis. MetaGene has received...
Applied Spectral Imaging (ASI) announces that its HiPath™ IHC imaging and analysis system provides computer-assisted PD-L1 interpretation. PD-L1 is seen as the current breakthrough therapeutic target in immuno-oncology. Following recent clinical advances, PD-L1 expression has become a key factor in determining the treatment for patients with...
